For someone considering The Wellness Solution, the most consequential detail may not be its advertised starting price. It is the difference between three descriptions of leaving the service: “Cancel anytime” on the homepage, a 48-hour cutoff in the terms, and 30 days’ notice on treatment pages. Those statements do not give a prospective member one clear operational deadline. Before authorizing recurring payments, the practical task is to establish which rule governs the specific purchase and how cancellation affects an order already underway.
The public pages consulted October 19, 2026, document a telehealth platform offering access to semaglutide, tirzepatide and a GLP-1 Microdose program. They also distinguish the platform from the independent practitioners and pharmacies responsible for treatment. This review examines that division of responsibility, the advertised payment bundle, renewal authorization, pharmacy restrictions and privacy qualifications. It is a documentary assessment of the service’s published commitments—not a verification of clinician credentials, an evaluation of an individual prescription or evidence that its treatments produce particular results.
At a glance
- Operator and responsibility
- The terms identify Ceifaa Health System Inc as the website operator; the platform says independent practitioners make clinical and prescribing decisions.
- Advertised starting price
- Plans start at $146 per month, described as an educational estimate confirmed after provider review; the minimum is not tied to a specific medicine or supply.Sources: [7]
- Recurring authorization
- A recurring monthly order authorizes an immediate charge and subsequent charges every 30 days, with electronic notice five to seven days before a scheduled transaction.Sources: [6]
- Conflicting cancellation deadlines
- The terms describe disabling auto-refill at least 48 hours before processing, while treatment FAQs require 30 days’ notice before the next billing cycle.
- Restricted pharmacy channel
- The terms require prescriptions to be filled through platform-accessible pharmacies and include a waiver of choosing another pharmacy.Sources: [6]
Resolve the exit terms before entering
The homepage’s cancellation language is reassuring at first glance, but it is not the whole agreement. The terms say a member may cancel by turning off auto-refill in the user portal up to 48 hours before the applicable monthly processing date. Treatment FAQs instead say memberships may be canceled with 30 days’ notice before the next billing cycle. The consulted documentation does not explain whether these provisions apply to different purchases or how a conflict between them is resolved.
That difference matters because the shorter deadline could lead a reader to believe a renewal remains avoidable when the longer deadline has already passed. Neither statement establishes a minimum membership duration on its own. A useful pre-enrollment request is written confirmation of the applicable notice period, the next processing date, the required cancellation method and whether any pending medication order remains payable. Our guide to cancellation notice and renewal dates explains why those are separate questions.
Cancellation also does not establish refund eligibility. Treatment pages say consultations, medical visits and fulfilled prescriptions are nonrefundable once services begin or medication is processed. That wording makes service and pharmacy status important, not merely the date a cancellation request is sent. The public language does not fully explain every intermediate order stage. Keep the accepted terms, cancellation confirmation and order-status messages together rather than treating an account’s inactive status as proof that a charge will be reversed.
| Issue | Published statement | What to confirm |
|---|---|---|
| Starting price | Plans from $146/month; confirmed after provider review | Exact medicine, formulation, supply and final charge |
| Renewal | Immediate charge, then every 30 days | First charge trigger and next processing date |
| Terms cancellation | Disable auto-refill at least 48 hours before processing | Whether this rule governs the selected plan |
| Treatment FAQ cancellation | 30 days’ notice before the next billing cycle | How this interacts with the 48-hour provision |
| Refund boundary | Services and fulfilled prescriptions become nonrefundable at stated processing stages | Whether work or medication processing has already begun |
What the monthly price actually authorizes
The advertised entry point is “Plans from $146” per month, accompanied by “confirmed after provider review” and “Educational estimate only.” It is therefore a documented starting price, not a confirmed semaglutide or tirzepatide quote. The consulted pages do not identify which medicine, formulation, quantity or supply period qualifies for that minimum. They also do not establish an introductory-versus-renewal price schedule, a multimonth discount or an upfront package. Those details should not be inferred from the monthly display.
There is more specificity about the payment structure once a recurring monthly order is placed. The terms authorize the listed product amount immediately and every 30 days thereafter until cancellation. They promise an electronic notification five to seven days before a scheduled transaction and a receipt after a successful charge. A 30-day interval is not necessarily the same calendar date each month. The documents do not clearly reconcile the immediate-charge authorization with every step of the advertised clinical approval process.
The homepage separately promises a $0 charge if the applicant is not approved. Treatment FAQs advertise flat-rate pricing without hidden fees, consultation charges or dose-change surcharges. The terms describe a bundled payment covering the pharmacy’s prescription charge, the medical group’s professional services and platform access. These are meaningful commitments, but laboratory work, administration supplies and external services are not clearly itemized. A written GLP-1 quote should establish those boundaries before payment authorization.
The platform is not the prescriber or pharmacy
The terms identify Ceifaa Health System Inc as the owner and operator of wellnesssolutionrx.com. The brand describes itself as a concierge telehealth platform facilitating access to independent, U.S. board-certified clinical providers and state-licensed compounding pharmacies. Those are the company’s descriptions, not independently verified credentials. The consulted documentation does not name the treating practitioners, medical groups or dispensing pharmacies, so a reader cannot use these pages alone to evaluate the particular professionals who would handle an account.
The platform expressly says it does not practice medicine, write prescriptions or dispense pharmaceuticals. Clinical evaluations and prescription decisions belong to independent licensed practitioners. Access begins with registration and an account, followed by health questions in an online assessment and provider review. The terms require a consultation through the platform, a determination that the prescription product is appropriate and issuance of a prescription before a prescription product can be obtained. Enrollment is therefore not a guarantee of medication.
This structure makes responsibility mapping an enrollment issue rather than a technicality. Ask who handles a clinical concern, a pharmacy discrepancy and a recurring-charge dispute—and obtain the names and contact routes for the entities actually assigned. The platform publishes a mailing address at 2090 Sugarloaf Parkway, Suite 215, Lawrenceville, Georgia 30045; that is not evidence of an in-person clinic there. Our guide to platform, clinician and pharmacy responsibilities provides a framework for separating those roles.
Program descriptions are not interchangeable offers
The semaglutide page describes a supervised program using a weekly injection and home delivery. Tirzepatide is presented as a provider-directed dual GLP-1/GIP program with flat-rate pricing, but its administration route is not established in the consulted description. The GLP-1 Microdose page markets a lower-dose approach for metabolic health, body composition and appetite rather than aggressive weight loss. Its specific ingredient and route are not documented. None of these descriptions connects a particular product or supply quantity to the $146 minimum.
Microdose marketing identifies people at or near their goal weight and people who poorly tolerated standard GLP-1 programs as potential candidates. That is the provider’s commercial positioning, not proof of benefit or an individualized eligibility determination. The site also advertises hormone therapy for men and women based on bloodwork and symptoms, with monitoring and adjustments, plus provider-reviewed peptide therapies prepared in a U.S. pharmacy. Those additional offerings do not establish what is included in a GLP-1 subscription.
The flat-rate program description expressly includes compounded medication prepared by partner pharmacies and shipped on a structured cadence. The site acknowledges that compounded medications are not FDA approved. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence. Before accepting a quote, establish the exact preparation offered; a program name is not a complete product description or evidence of its outcomes.
Location and screening limit the enrollment promise
The homepage advertises nationwide telehealth, but more specific documents qualify that message. The terms restrict service to states where Ceifaa operates, while the contact page says the business operates through telehealth in states where it is licensed. Neither provides a concrete state list in the consulted material. Availability therefore needs confirmation for both the applicant’s state and the selected program. A national marketing statement is not sufficient documentation that every product is available in every state.
The terms also require the patient to be physically in the same state as the shipping address listed in the account during a provider consultation. That condition can matter for travelers or people with more than one residence. Access is limited to adults at least 18 years old, or the local age of majority if higher, who accept the agreement. These are service conditions; they do not establish that a particular applicant will receive a prescription after completing the assessment.
The semaglutide page separately lists a candidate profile of adults 18 or older with BMI of at least 27, or at least 25 with weight-related conditions. Its published exclusions include personal or family history of medullary thyroid carcinoma or MEN 2, pregnancy, breastfeeding or pregnancy plans, active pancreatitis and untreated severe gastrointestinal disease. These are the provider’s stated screening criteria, not a complete individualized evaluation. Applicants should present their history to the treating clinician rather than interpreting the page as approval.
Pharmacy restrictions continue after approval
A favorable prescribing decision does not leave the pharmacy channel open. The terms say prescriptions will be filled through pharmacies accessible through the platform. Purchasing a service or product that includes a prescription entails a stated waiver of the right to have it filled at a pharmacy of the patient’s choice. That is a material purchasing restriction. Anyone expecting to use a local pharmacy should resolve that expectation before enrolling, not after a clinician has issued the prescription.
The pharmacy is responsible for shipping the prescribed product directly to the patient. Treatment pages advertise temperature-controlled, unmarked packaging, while the terms warn that prescription products will not be dispensed in child-resistant containers. The homepage advertises free two-to-three-day shipping. That shipping statement does not establish the interval from approval to dispatch or a guaranteed arrival date measured from application. Similarly, the promise of provider review within one business day describes review, not dispensing or delivery.
The nonrefundability language makes it especially useful to ask when an approved prescription becomes a processed pharmacy order. Our guide to prescription and pharmacy order status explains the distinction without assuming that cancellation reverses fulfillment. Separately, FDA advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. That guidance is relevant despite the advertised temperature-controlled packaging; packaging language alone cannot establish the condition of a particular delivery.
Follow-up access needs an operational definition
The program includes direct messaging with the provider through a secure patient portal between scheduled check-ins. It also advertises structured reviews intended to adjust the protocol and overall care plan to the patient’s response. Those are useful service descriptions, but the consulted pages do not set a specific check-in frequency or a clinician-message response deadline. Before paying for recurring access, ask what initiates a review, who responds to messages and how clinical concerns are escalated when the usual provider is unavailable.
The contact page lists info@wellnesssolutionrx.com and (470) 284-0204, with clinical hours Monday through Friday, 9 a.m. to 5 p.m.; it does not specify a time zone. It also promises a team response within 24 hours for contact-form submissions. That administrative response statement is distinct from the homepage’s one-business-day provider review claim. Neither should be interpreted as a promise of immediate clinical attention, an around-the-clock service or a guaranteed resolution within the stated period.
Privacy promises require the same close reading
Treatment FAQs say medical information is shared only with the assigned provider and dispensing pharmacy, followed by a broader promise never to sell or share data. The terms provide a more qualified description of the platform’s HIPAA position: Ceifaa is not a covered entity, though it may act as a business associate of a pharmacy or medical group in certain circumstances. This does not independently establish compliance or noncompliance. It does mean that a general HIPAA marketing statement is not the complete account of the relationships.
The California privacy notice adds that certain personal information may be made available to third parties for advertising measurement, improvement and more relevant content or offers. It says those disclosures may count as a “sale” or “share” under California law. This is not evidence that medical records are sold, but it qualifies a blanket reading of the no-sharing promise. Ask which information categories are involved, which choices apply to the account and which entity handles a privacy request before submitting sensitive information.
Questions & answers
Does $146 a month buy a specific semaglutide supply?
The consulted pages do not establish that. The homepage advertises plans from $146 per month as an educational estimate, confirmed after provider review. It does not identify the medicine, formulation, quantity or supply period available at that minimum. Request the final product-specific quote and renewal amount rather than treating the headline as a semaglutide price.
Can I cancel two days before the next charge?
The terms describe disabling auto-refill at least 48 hours before monthly processing, but treatment FAQs require 30 days’ notice before the next billing cycle. The public documents do not reconcile those deadlines. Obtain written confirmation for the selected subscription before relying on either rule. Also ask whether an already processed medication order remains chargeable and nonrefundable.
Will The Wellness Solution prescribe the medication itself?
The platform says it does not prescribe, practice medicine or dispense drugs. Independent licensed practitioners perform the evaluation and make prescribing decisions; a consultation and an issued prescription are required. Ceifaa Health System Inc operates the website. Ask for the assigned clinician, medical group and pharmacy identities because the consulted public documentation does not name those treating entities.
Can I send the prescription to my usual pharmacy?
The published terms restrict fulfillment to pharmacies accessible through the platform and include a waiver of choosing another pharmacy when buying a prescription-inclusive service or product. Do not assume an outside-pharmacy option is included. Ask which pharmacy will dispense the specific preparation and how to contact it before authorizing a purchase.
Does “no insurance required” mean insurance is accepted?
No. That statement means insurance is not required to use the advertised service; it does not establish that the platform bills a health plan or that a plan will reimburse the purchase. The consulted documentation does not clarify insurance acceptance or reimbursement paperwork. The published bundle covers pharmacy, professional-service and platform components, but laboratory and external-service costs remain insufficiently itemized.
How quickly can I expect review, support and delivery?
The homepage advertises provider review within one business day and free two-to-three-day shipping. The contact page separately promises a team response within 24 hours for form inquiries. These are different stages, not a combined arrival guarantee. The consulted documentation does not establish the approval-to-dispatch interval. Clinical hours are weekdays, 9 a.m. to 5 p.m., without a stated time zone.
Our assessment
The Wellness Solution documents a recognizable service bundle: independent clinical review, partner-pharmacy medication, portal messaging and direct delivery, with advertised flat-rate pricing and no consultation or dose-change surcharges. Its main documentary weakness is inconsistency at consequential boundaries. Cancellation deadlines conflict, nationwide language is qualified by unspecified state availability, and broad privacy promises require narrower reading. The $146 minimum also remains unconnected to a defined product and supply. A reasonable next step is to request a written, product-specific agreement identifying the treating entities, total charges, renewal date, applicable cancellation rule and pharmacy-processing refund boundary. Without those answers, the public materials do not provide a sufficiently clear account of the ongoing financial commitment.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- The Wellness Solution — treatments/tirzepatide ↗
- The Wellness Solution — treatments/semaglutide ↗
- The Wellness Solution — contact ↗
- The Wellness Solution — privacy ↗
- The Wellness Solution — terms ↗
- The Wellness Solution — official website ↗
- The Wellness Solution — treatments/glp 1 microdose ↗